Healthcare provider profile · identity verified

Ricardo Pedraza, MD

Internal Medicine · SAN ANTONIO, TX · NPI 1659868099

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	934	297
Amlodipine Besylate	Amlodipine Besylate	617	197
Lisinopril	Lisinopril	560	174
Rosuvastatin Calcium	Rosuvastatin Calcium	481	155
Metformin Hcl	Metformin Hcl	435	137
Levothyroxine Sodium	Levothyroxine Sodium	357	111
Losartan Potassium	Losartan Potassium	331	111
Gabapentin	Gabapentin	284	104
Albuterol Sulfate Hfa	Albuterol Sulfate	271	84
Pantoprazole Sodium	Pantoprazole Sodium	255	98
Tamsulosin Hcl	Tamsulosin Hcl	252	84
Montelukast Sodium	Montelukast Sodium	229	84
Jardiance	Empagliflozin	220	70
Omeprazole	Omeprazole	193	69
Metoprolol Tartrate	Metoprolol Tartrate	183	61
Hydrochlorothiazide	Hydrochlorothiazide	177	48
Glipizide Er	Glipizide	173	60
Metoprolol Succinate	Metoprolol Succinate	173	55
Furosemide	Furosemide	168	69
Ozempic	Semaglutide	168	30
Simvastatin	Simvastatin	168	51
Carvedilol	Carvedilol	159	56
Alendronate Sodium	Alendronate Sodium	156	51
Fluticasone Propionate	Fluticasone Propionate	151	61
Metformin Hcl Er	Metformin Hcl	129	45
Pravastatin Sodium	Pravastatin Sodium	124	39
Trulicity	Dulaglutide	121	35
Glipizide	Glipizide	114	41
Tizanidine Hcl	Tizanidine Hcl	96	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	27
Sertraline Hcl	Sertraline Hcl	88	32
Trazodone Hcl	Trazodone Hcl	88	35
Ibuprofen	Ibuprofen	87	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	78	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	26
Finasteride	Finasteride	76	26
Meloxicam	Meloxicam	73	29
Hydralazine Hcl	Hydralazine Hcl	72	22
Allopurinol	Allopurinol	70	22
Tramadol Hcl	Tramadol Hcl	66	18
Nifedipine Er	Nifedipine	65	22
Clopidogrel	Clopidogrel Bisulfate	64	25
Duloxetine Hcl	Duloxetine Hcl	63	21
Januvia	Sitagliptin Phosphate	61	18
Eliquis	Apixaban	60	15
Famotidine	Famotidine	58	23
Potassium Chloride	Potassium Chloride	58	19
Olmesartan Medoxomil	Olmesartan Medoxomil	50	17
Enalapril Maleate	Enalapril Maleate	49	18
Lovastatin	Lovastatin	47	15
Hydroxyzine Hcl	Hydroxyzine Hcl	46	18
Triamcinolone Acetonide	Triamcinolone Acetonide	44	28
Alprazolam	Alprazolam	43	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	22
Pioglitazone Hcl	Pioglitazone Hcl	42	18
Esomeprazole Magnesium	Esomeprazole Magnesium	41	14
Acetaminophen-Codeine	Acetaminophen With Codeine	40	11
Diclofenac Sodium	Diclofenac Sodium	40	18
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	14
Clotrimazole	Clotrimazole	36	21
Doxazosin Mesylate	Doxazosin Mesylate	36	11
Spironolactone	Spironolactone	36	15
Xarelto	Rivaroxaban	36	suppressed
Celecoxib	Celecoxib	35	15
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	33
Mirtazapine	Mirtazapine	34	14
Paxlovid	Nirmatrelvir/Ritonavir	31	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	11
Methocarbamol	Methocarbamol	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Torsemide	Torsemide	30	11
Clonazepam	Clonazepam	28	11
Myrbetriq	Mirabegron	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Prednisone	Prednisone	26	20
Spiriva Handihaler	Tiotropium Bromide	26	suppressed
Valsartan	Valsartan	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	25	20
Irbesartan	Irbesartan	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	24	suppressed
Baclofen	Baclofen	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	20
Buspirone Hcl	Buspirone Hcl	22	suppressed
Lorazepam	Lorazepam	22	11
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Atenolol	Atenolol	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Bydureon Bcise	Exenatide Microspheres	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Azithromycin	Azithromycin	18	18
Levetiracetam	Levetiracetam	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Chlorthalidone	Chlorthalidone	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Topiramate	Topiramate	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Fluconazole	Fluconazole	16	14
Hydrocortisone	Hydrocortisone	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	15	suppressed
Methylprednisolone	Methylprednisolone	15	14
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Naproxen	Naproxen	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Estradiol	Estradiol	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Mounjaro	Tirzepatide	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error